Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F01U4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,442
Award facts
- Contract value 100% obligated
- $15,441.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,441.58 to AmerisourceBergen Drug Corp for the supply of STELARA 45 mg/0.5 mL syringes on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. STELARA is a biopharmaceutical product used to treat various autoimmune and inflammatory conditions, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. The IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills such delivery orders under this master contract framework, demonstrating its substantial role as a critical pharmaceutical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F01U4?
SPE2DR26F01U4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F01U4 worth?
The government has obligated $15,442 on SPE2DR26F01U4.
Is contract SPE2DR26F01U4 an order under another contract?
Yes. SPE2DR26F01U4 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F01U4 competed?
The extent of competition for SPE2DR26F01U4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award